Services
Ways I help therapeutics companies and their investors.
Fractional Chief Business Officer
For early- and mid-stage therapeutics companies that need senior BD leadership without a full-time hire.
Fractional Chief Business Officer
Serving as your acting CBO / Head of Business Development — leading corporate development, sourcing and evaluating cross-border assets, and structuring in- and out-licensing deals. You get an experienced operator and an active network from day one, on a fractional or interim basis.
Strategic Advisory & Venture Positioning
For scientific founders moving from discovery to a venture-backed company, or preparing to raise.
Strategic Advisory & Venture Positioning
Helping you see your company the way institutional investors will. I refine the pitch narrative, sharpen platform positioning, help build the right investor syndicate, and pressure-test the development plan — so the raise starts from a position of strength.
Asset Evaluation & Translational Strategy
For companies derisking their own pipeline ahead of a financing or partnering milestone.
Asset Evaluation & Translational Strategy
Deep technical evaluation of emerging modalities, with hands-on depth in ophthalmology, immunology, and other therapeutic areas. I read the early clinical and imaging data, translate signals into commercial positioning, and map the competitive landscape before key milestones.
Scientific & Financial Due Diligence
For venture and private-equity funds underwriting an investment or acquisition.
Scientific & Financial Due Diligence
Buy-side diligence that pairs molecular biology with financial discipline. Backed by a Ph.D. in biochemistry, a CFA charter, and strong training at several venture firms, I assess mechanism of action and pipeline viability, weigh IP strength, and model clinical and regulatory probability to sharpen your decision.
Not sure which fits?
Tell me what you're building and where you're headed, and we'll figure out the right engagement together.